Full-Time

Therapeutic Specialist HIV

Posted on 5/18/2025

Gilead Sciences

Gilead Sciences

10,001+ employees

Develops and commercializes biopharmaceuticals

No salary listed

Mid, Senior

Company Historically Provides H1B Sponsorship

Milan, Metropolitan City of Milan, Italy

Category
Field Sales
Sales & Account Management
Requirements
  • Has a proven track record of successful pharmaceutical medical or healthcare sales experience and relevant disease/product knowledge, along with strong influencing and negotiating skills, homed in highly competitive markets.
  • Is familiar with industry trends and remains current with competitor’s resources and practices.
  • Proactively identifies issues, opportunities, and resolutions and is able to present and effectively communicate issues and recommendations to marketing and sales management.
  • Serves as a technical expert of assigned product, therapeutic/disease classes, and patient needs in order to educate/influence key physicians/community members.
  • Demonstrates a sound understanding of external business drivers and internal company operations.
  • Must be self-motivated and able to work with a high level of autonomy and independence.
  • Typical candidates will possess a BA or BS degree, and relevant sales experience within the pharmaceutical or healthcare industry.
  • Experience must include consolidated experience in specialty sales or the appropriate therapeutic target.
  • Achievement of any mandatory country-specific pharmaceutical sales certifications is essential.
Responsibilities
  • Responsible for achieving coverage and frequency targets, and consistently achieving sales targets in assigned territory.
  • Fulfils a regional training role to develop the key skills of other team members, and acts as a mentor for junior staff.
  • Initiates systems to regularly measure sales progress and action plans. Documents and provides feedback on performance.
  • May assist others with their individual plans and is productive at developing in-depth market interpretation of sales analysis data.
  • Manages territory budgets for customer contacts, speaker events and other miscellaneous external expenditures.
  • May work in collaboration with outside partner companies to co-promote products or services.
  • May represent company at professional events and promote company products at such events.
  • Works cooperatively with Medical Science Liaisons, National Account Managers, Marketing and other internal Gilead team members on various cross-functional projects.
  • Organizes sales initiatives within the market as directed and follows up on these to ensure their successful completion.
  • May take the lead on projects within team e.g. liaison role with marketing, meetings coordinator etc.
  • Completes necessary administrative tasks in a timely manner e.g. updating customer database, expenses etc.
  • Operates in compliance with Gilead commercial compliance policy, and all applicable federal and state laws and guidance relating to product promotion and information dissemination.
Desired Qualifications
  • Engagement and commitment to the Gilead Core Values, which are: Teamwork – Working together, Excellence – Being your best, Accountability – Taking personal responsibility, Integrity – Doing what’s right, Inclusion – Encouraging Diversity.

Gilead Sciences is a biopharmaceutical company that develops and sells medicines for various serious health conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company focuses on extensive research and development to create new therapies, which are then approved by regulatory authorities before being marketed to healthcare providers, hospitals, and pharmacies. Gilead stands out from its competitors by investing heavily in R&D and forming strategic partnerships, such as with SAP Ariba, to improve its supply chain and ensure sustainable practices. The company's goal is to enhance health equity and access to care globally, working with communities to remove barriers to healthcare and make its medicines available to those in need.

Company Size

10,001+

Company Stage

IPO

Headquarters

Foster City, California

Founded

1987

Simplify Jobs

Simplify's Take

What believers are saying

  • Gilead's $32 billion U.S. investment will create over 3,000 jobs by 2028.
  • The reformulation of lenacapavir offers long-acting HIV prevention, improving patient adherence.
  • Gilead's top five ranking in the Most JUST list highlights its corporate responsibility.

What critics are saying

  • A $202 million settlement for legal violations may damage Gilead's reputation.
  • Layoffs of 150 employees, including senior management, could disrupt company operations.
  • AI-driven drug discovery companies pose a competitive threat to Gilead's traditional R&D.

What makes Gilead Sciences unique

  • Gilead focuses on innovative medicines for unmet needs like HIV/AIDS and liver diseases.
  • The company invests heavily in R&D to maintain a robust pipeline of new treatments.
  • Gilead's partnerships enhance product offerings and expand market reach globally.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Company News

Fierce Pharma
May 8th, 2025
Gilead tees up $11B in new US manufacturing, R&D investments

This time it's Gilead coming to the table with a fresh $11 billion in hand to spend across its manufacturing and research centers in the U.S.

Gilead Sciences
May 7th, 2025
Gilead U.S. Investment to Create $43 Billion in Value to U.S. Economy

Gilead to invest $32 billion in U.S. manufacturing and R&D through 2030 and create more than 3,000 direct and indirect jobs by 2028

Constantine Cannon
May 5th, 2025
Gilead Pays $202M to Settle False Claims Act Kickback Charges

On April 29, the Department of Justice (DOJ) announced that California-based pharmaceutical giant Gilead Sciences agreed to pay $202 million to settle charges of violating the False Claims Act and Anti-Kickback Statute.

Financial Modeling Prep
May 2nd, 2025
Amgen Inc. (NASDAQ:AMGN) Surpasses Earnings and Sales Estimates in Q1 2025

Amgen competes with other biotech giants like Gilead Sciences and Biogen.

SFist
Apr 2nd, 2025
April Fool's Day Around the Bay: Bob Lee's Family Has Sued His Convicted Killer Nima Momeni

Foster City-based HIV drug company Gilead Sciences is laying off nearly 150 people, and the job cuts are significant among senior members of the company's management.